Psychedelic Program for the Treatment of Mental Diseases
Brightmindsbio19 Jan, 2022Health
Bright Minds Biosciences (?Bright Minds,? ?BMB? or the ?Company?) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today provided a scientific update on the advancement of its novel 5-HT2A psychedelic program for the treatment of mental diseases.
Related Bookmarks
- Mitomycin C Injection: A Potent DNA Crosslinker
- SOAP Documentation - SOAPassist
- Acupuncture Ease Symptoms COVID-19 Long-Hauler
- Generic Symbicort 200/6mcg Inhaler
- online appointment scheduling | Counselling and Therapy Services
- Is Orthopedic Cervical Pillow Really Required?
- Vasectomy Perth
- Ultrasound scan near me in Delhi NCR - Star Imaging
- Memory Foam Pillow Or Its Benefits
- Can you buy Hydrocodone online with Credit Card
Recent Profiles
Elevate Accounting
Fennell Estates
Brandbuy Limited
Great Lakes Preserves
Nicotine Vault – Your Trusted Source For Nicotin
Amit Digital
Moto X3m - Motox3monline.net
J4 Jacket
Karlsson Svenstrup
One Love Golf Cart Rental